| Literature DB >> 34249868 |
Wenzhuo Ming1, Yi Zhang2, Yiwei Sun1, Guangming Bi1, Jing Su2, Zhutao Shao1, Dali Meng1.
Abstract
Four new guaiane-type sesquiterpenes, argyin H-K (1-4), and two known analogues (5 and 6) were isolated from the leaves of Artemisia argyi Lévl et Vant. The new compounds were characterized by the basic analysis of the spectroscopic data obtained (1H NMR, 13C NMR, HMBC, and NOESY experiments), and their absolute configurations were determined by empirical approaches, combined with the exciton chirality method and electronic circular dichroism calculations. To further understand the antitumor effects of A. argyi, the antiproliferative activities of these compounds against A549, MCF-7, and HepG2 cell lines were tested in vitro using CCK-8 assays. The results showed that these compounds had significant antiproliferative effects on MCF-7, with IC50 values of 15.13-18.63 μM, which were superior to that of oxaliplatin (i.e., IC50 22.20 μM).Entities:
Keywords: Artemisia argyi; antiproliferative; antitumor; configuration determination; guaiane-type sesquiterpenoids
Year: 2021 PMID: 34249868 PMCID: PMC8263895 DOI: 10.3389/fchem.2021.698700
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
FIGURE 1Key HMBC (A) and NOESY (B) correlations of compound 1.
FIGURE 2Structures of compounds one to six isolated from A. argyi.
1H NMR (DMSO-d 6, 600 MHz) and 13C NMR (DMSO-d 6, 150 MHz) spectroscopic data for compounds one to four.
| Position | 1 | 2 | 3 | 4 | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| 1 | 76.6 | 76.8 | 146.5 | 78.0 | ||||
| 2 | 43.7 | α 1.68, br. d (13.5) | 43.6 | α 1.68, dd (13.5, 6.8) | 128.8 | 5.55 d (2.1) | 47.4 | α 2.11, br. d (14.2, 6.3) |
| β 2.00, overlapped | β 1.98, dd (13.5, 10.5) | |||||||
| 3 | 76.5 | 4.05, m | 76.7 | 4.05, m | 82.5 | 4.29 d (2.1) | 78.8 | 3.54, m |
| 4 | 80.7 | 80.8 | 84.7 | 79.6 | ||||
| 5 | 63.5 | 2.15, d (11.7) | 63.6 | 2.16, d (11.7) | 59.4 | 2.97 d (11.2) | 61.0 | 2.26, d (9.6) |
| 6 | 77.7 | 4.20, dd (11.7, 8.6) | 77.7 | 4.22, dd (11.5, 8.7) | 77.9 | 4.38, dd (11.2, 9.6) | 75.9 | 4.41, t (9.6) |
| 7 | 47.7 | 3.21, m | 47.6 | 3.23, m | 47.2 | 3.95, tt (9.6, 3.1) | 41.8 | 4.24, tt (9.6, 3.2) |
| 8 | 74.5 | 4.85, dd (10.2, 4.5) | 74.4 | 4.87, dd (9.4, 5.0) | 72.5 | 5.13, ddd (9.6, 5.5, 3.1) | 73.0 | 5.31, ddd (9.6, 5.2, 1.5) |
| 9 | 36.9 | 2.75, dd (12.1, 9.6) | 36.6 | 2.72, dd (12.5, 9.0) | 44.5 | 1.94, m | 122.0 | 5.41, dd (5.2, 1.5) |
| 2.45, dd (12.1, 4.5) | 2.42, dd (12.5, 5.0) | |||||||
| 10 | 146.0 | 146.0 | 69.7 | 144.6 | ||||
| 11 | 137.4 | 137.6 | 139.4 | 139.0 | ||||
| 12 | 169.8 | 169.7 | 169.9 | 169.8 | ||||
| 13 | 122.8 | 6.04, d (3.3) | 122.5 | 6.05, d (2.8) | 120.4 | 5.98, d (3.4) | 121.1 | 6.04, d (3.0) |
| 5.68, d (3.3) | 5.66, d (2.8) | 5.40, d (3.4) | 5.48, d (3.0) | |||||
| 14 | 116.2 | 5.03, s | 116.1 | 5.01, s | 31.0 | 1.33, s | 25.3 | 1.81, s |
| 5.18, s | 5.19, s | |||||||
| 15 | 16.5 | 1.02, s | 16.6 | 1.03, s | 18.2 | 1.12, s | 23.6 | 1.23 s |
| 1′ | 172.1 | 175.4 | 167.2 | 167.0 | ||||
| 2′ | 43.0 | 2.04, m | 41.1 | 2.45, m | 127.8 | 127.5 | ||
| 3′ | 25.7 | 2.33, m | 26.3 | 1.63, m | 138.6 | 6.18, dq (1.2,7.0) | 139.0 | 6.19, dq (7.3, 1.6) |
| 2.27, m | 1.44, m | |||||||
| 4′ | 22.6 | 0.93, d, (6.6) | 12.0 | 0.88, t, (7.0) | 16.0 | 1.96, dq (7.3, 1.7) | 16.1 | 1.94, dt (7.3, 1.6) |
| 5′ | 22.5 | 0.94, d, (6.6) | 17.3 | 1.14, d, (7.0) | 20.8 | 1.87, t (1.7) | 20.7 | 1.87, t (1.6) |
| 1-OH | 5.13, s | 5.14, s | 5.26, s | |||||
| 3-OH | 4.80, d, (4.6) | 4.81, d, (4.6) | ||||||
| 4-OH | 4.31, s | 4.33, s | 4.51, s | |||||
FIGURE 3ECD spectra of compounds 1, 2 (A), and 3 (B) (data calculated using the TDDFT method at the B3LYP/6–31 + g(d,p) level.).
FIGURE 4ECD exciton chirality of compounds 1 (A), 2 (B), 3 (C), and 4 (D).
FIGURE 5Key HMBC (A) and NOESY (B) correlations of compound 2.
FIGURE 6Key HMBC (A) and NOESY (B) correlations of compound 3.
FIGURE 7Key HMBC (A) and NOESY (B) correlations of compound 4.
Antiproliferative activities of compounds one to six against A549, HepG2, and MCF-7 cell lines.
| Samples | IC50 values (μM) | ||
|---|---|---|---|
| A549 | HepG2 | MCF-7 | |
| Comp.1 | 24.32 ± 0.34 | 20.42 ± 1.28 | 18.63 ± 1.93 |
| Comp. 2 | 22.78 ± 1.70 | 20.02 ± 0.83 | 18.59 ± 0.48 |
| Comp. 3 | 17.29 ± 0.98 | 15.13 ± 1.56 | 15.13 ± 0.29 |
| Comp. 4 | 22.49 ± 0.78 | 16.30 ± 2.90 | 16.30 ± 1.62 |
| Comp. 5 | 23.96 ± 0.22 | 18.82 ± 0.68 | 19.33 ± 1.59 |
| Comp. 6 | 19.81 ± 1.32 | 18.17 ± 0.12 | 21.62 ± 0.44 |
| Oxaliplatin | 7.22 ± 1.33 | 13.76 ± 0.54 | 22.20 ± 0.78 |
Each value represents the mean ± SD of three independent experiments.